emc易倍官网入口
Period
Filter by
recent search
Showing: 1 – 5 of 219 stories
03 June 2026 – 2 mins read
Choosing the hardest problems: why Ipsen focuses where unmet need is greatest?
In biopharmaceutical research, not all challenges are equal. Some of the most meaningful opportunities lie in areas defined by complex biology, limited evidence, and patients who have waited far too long for effective treatment options.??
28 May 2026 – 3 mins read
Why?post approval?evidence?is?redefining the?future of?patient?care?
In today’s rapidly evolving treatment landscape the approval of a medicine is no longer the finish line; it’s just the beginning. Real world evidence (RWE), post-hoc analyses and structured Phase IV studies all offer new opportunities for scientific learning. At Ipsen, we’re committed to pursuing the unanswered questions, generating robust evidence that goes beyond medicine development, which provides broader long-term evidence-based perspectives for the communities we serve.?
26 May 2026 – 2 mins read
“I Really Witnessed It?First Hand”: How Personal Experience Shapes Loubna Ouriaghli’s Work?
A diagnosis is supposed to be the end of the uncertainty. For some families, it is also the moment they realize there is nothing more medicine can offer. Loubna Ouriaghli, Head of Government Affairs & Policy at Ipsen, witnessed that moment with her own mother who was diagnosed with a rare disease.??She saw the symptoms appear one by one, the years it took to finally have an answer and the silence that followed when that answer came with no treatment.?
21 May 2026 – 0 mins read
Driving Progress in Rare Liver Disease: Ipsen at EASL Congress 2026
We’re excited to be at the European Association for the Study of the Liver (EASL) Congress 2026, Europe’s largest event dedicated to liver health where doctors, scientists, allied health professionals, patients, and industry partners come together to share knowledge, highlight scientific breakthroughs, and build meaningful connections.
19 May 2026 – 2 mins read
A moment worth?remembering:?what SCALE tells us about the future of aesthetics?
There are moments that stay with you. Not because of a single slide or headline, but because you can feel something changing. Expectations shift. Standards rise. A new chapter begins.?
